Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. This change does not alter study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-03-11T15:55:22.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous government funding lapse notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:01:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a notice about a lapse in government funding and the NIH Clinical Center's operating status. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T00:01:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Add glossary display and new QC/label elements: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data' capitalization, and 'Revision: v3.4.0'. Deletions remove the older lowercase labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' along with the older 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T22:43:28.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; this appears to be a minor system update with no change to the study details presented.
    Difference
    0.0%
    Check dated 2026-01-13T17:45:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Maryland is now listed as a location under the Locations section, updating the trial's geographic availability. The Maryland Locations subsection and the HHS Vulnerability Disclosure link were removed as part of revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:00:43.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.